(MD+DI) – CEO Bryan Hanson said the company’s funnel for Rosa placements is the strongest it’s ever been and the surgical robotic system is expected to be a key growth driver for Zimmer Biomet in 2020. […]
(MD+DI) – Back in April, MD+DI published an article offering five reasons that this would be Zimmer Biomet’s comeback year, and the Warsaw, IN-based company did not let us down. In fact, Zimmer Biomet accomplished even more in 2019 than we could have predicted at that time. […]
(MD+DI) – An industry analyst expects Zimmer Biomet’s Rosa Knee robotic system to represent a formidable competitor to Stryker’s Mako Knee after the Rosa Knee’s full launch later this year. However, both Mako and Rosa have their strengths and weaknesses, and neither is clearly superior, the analyst said. […]
(MD+DI) – Zimmer Biomet’s revenue growth is expected to accelerate during 2019 as the company shifts back to offense after addressing supply issues that have plagued the orthopedic device maker since 2016. […]
(MD+DI) – After spending 2018 dealing with quality control remediation and supply chain issues, Zimmer Biomet expects to return to market growth by 2020. […]
(MD+DI) – Surgical robotics is expected to be hotter than ever in 2019, particularly on the orthopedics side, and Zimmer Biomet is sliding into the market just in time. […]
Copyright © 2020 | MH Magazine WordPress Theme by MH Themes